flosz | DeBeurs.nl



Draadje OT, bijzaken & geleuter in de marge!

Ancestry, 23andMe, MyHeritage and Gene by Gene.....In 2016, 23andme began selling access to anonymised data to more than 13 drug firms. Genentech reportedly paid $10m (8.3m) to look at the genes of...

Forumberichten 07 aug | Door: flosz Forum: uniQure

Morphosys-Galapagos, Therapeutic Antibodies

$MOR Announces Intention to Submit Marketing Authorization Application for Tafasitamab to EMA. $MOR Discloses Biomarker to Stratify Patient Population in B-MIND Study of Tafasitamab plus Bendamusti...

Forumberichten 06 aug | Door: flosz Forum: Galapagos

Wat is de waarde van uniQure?

Why biotech companies are often at the whim of things they cannot control, in one chartwww.statnews.com/2019/07/31/why-biote...twitter.com/adamfeuerstein/status/115...

Forumberichten 31 jul | Door: flosz Forum: uniQure

Huntington’s Disease

Risk and rewardThe main potential advantage of AMT-130 is also its biggest potential drawback. It’s a gene therapy, so a single treatment is expected to be permanent.If everything works out as plan...

Forumberichten 17 jul | Door: flosz Forum: uniQure

AMT-180 Hemophilia A

Nathwani discussed the current status of the #hemophilia A gene therapy programs. #ISTH2019 twitter.com/profmakris/status/1147997... No mention of Freelines Hem A. Considering his affiliation with ...

Forumberichten 08 jul | Door: flosz Forum: uniQure

Hemofilie B; nog steeds on track?

Nathwani (UCL/St. Jude, Freeline) showed stable FIX level for 8 years after wild type fix gene therapy in #hemophilia. #ISTH2019https://twitter.com/profmakris/status/1147992232701468672?s=21Nathwa...

Forumberichten 08 jul | Door: flosz Forum: uniQure

Waar beleggen jullie nog meer in

Gene-Therapy Firm UniQure Explores Options Including SaleUniQure NV is exploring options including a potential sale amid interest from pharmaceutical companies looking to expand in gene therapy, pe...

Forumberichten 16 jun | Door: flosz Forum: Galapagos

Spark Therapeutics, Inc. (ONCE)

FTCs scrutiny of the Roche-Spark acquisition is a big deal, and just might have biopharma lawyers a bit nervous.twitter.com/byjongardner/status/11388...The main supposition is that Roche could kill...

Forumberichten 13 jun | Door: flosz Forum: uniQure

Inhoudelijk Toledo Draadje

quote:Lama Daila schreef op 8 jun 2019 om 10:21:Gestart op het Light-draadje, maar het zal (hoogstwaarschijnlijk) hier op het Toledo-draadje ook op zijn plaats.Galapagos heeft een nieuw patent gepu...

Forumberichten 10 jun | Door: flosz Forum: Galapagos

Fabry disease

quote:Vitavita schreef op 31 mei 2019 om 00:27:May 30, 2019 04:05 PMKortom, de huidige relationship is onduidelijk.Zie www.iex.nl/Forum/Topic/1309036/1/nieu...

Forumberichten 31 mei | Door: flosz Forum: uniQure

PubMed UniQure

In-depth characterization of a Mifepristone regulated expression system for AAV5-mediated gene therapy in the liver www.cell.com/molecular-therapy-family...

Forumberichten 20 mei | Door: flosz Forum: uniQure

Hartfalen en overname InoCard

Bristol-Myers Squibb CollaborationIn 2015, we entered into an agreement with BMS that provides exclusive access to our gene therapy technology platform for multiple targets primarily focused on car...

Forumberichten 07 mei | Door: flosz Forum: uniQure

Spinal Muscular Atrophy (SMA)

$QURE #ASGCT19 APRIL29-MAY2,WASHINGTON,D.C. Therapeutic Rescue of Spinal Muscular Atrophy Mouse Models with AAV9-Exon Specific U1 snRNASpinal Muscular Atrophy results from loss-of-function mutation...

Forumberichten 26 apr | Door: flosz Forum: uniQure


Lid sinds 13 feb 2008
Laatste bezoek 07 aug 2019
Aantal posts 6.884
Gegeven aanbevelingen 2.771
Ontvangen aanbevelingen 5.274
Aanbevelingen/Posts 0,7661
Top posts Aanb.
New contracts awarded for QV® and HepavaxGene
Crucell - 23-sep-08 07:52
Vaccination drive to replace Indian vials
Crucell - 31-mrt-10 08:25
The Street- What Buffet Would Buy Now
Crucell - 18-mrt-08 15:35
‘Hoeveel fouten mag je maken?’
Crucell - 11-mrt-10 19:20
Dear fellow shareholder,
Crucell - 16-mei-08 22:01
Crucell <> DSM & Patrys.
Crucell - 26-okt-08 02:21
Offer Document Dated [●] [●] 2010
Crucell - 14-nov-10 14:35
*Inventarisatie en belangenvereninging*
Crucell - 22-sep-10 20:01
Mogelijk gemaakt door IEX.nl